SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech - Technical Analysis -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (347)4/18/2002 9:54:33 AM
From: Jibacoa  Read Replies (1) | Respond to of 544
 
Good up-gap today on TRMS on the news from Roche.<g>

" Final Phase III tests showed T-20 significantly reduced the amount of virus in the the blood in resistant patients, when used in combination with existing therapies.

Roche is developing the drug -- the first in a new class of products known as fusion inhibitors -- with U.S. biotechnology group Trimeris Inc (NasdaqNM:TRMS - news).

``These results are even better than the positive results of earlier studies had led us to expect,'' said William Burns, Roche's head of pharmaceuticals.

The latest clinical data examined the effects of T-20, which must be given by injection, for 24 weeks on 491 patients who had shown resistance to each of the three classes of currently available antiretrovirals.

The positive data will form the basis of a dossier which Roche and Trimeris plan to submit to regulatory authorities in order to win marketing approval. Trimeris will co-market the product in North America, while Roche will market it elsewhere.

T-20 has fast track designation from the U.S. Food and Drug Administration and the companies hope to secure regulatory approval by early next year.

siliconinvestor.com

It may get to test the November 2000 H at 80.<g>

siliconinvestor.com

But I think I will wait to see if it will close some of today's up-gap. My order is in at 45 albeit I may have to increase it if it starts to move up from the 49 level.<g>

Bernard